[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fuickUqA6YfLjcS2qcmJkilR5v5m_RgfMQagW-luCQCg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Hebrew SeniorLife",[4],37,false,8,1,8357,0,35,[14,17,20,22,25,28,30,32],{"name":15,"count":16},"Aging",13,{"name":18,"count":19},"Alzheimer Disease",5,{"name":21,"count":19},"Dementia",{"name":23,"count":24},"Depressive Symptoms",3,{"name":26,"count":27},"Major Depressive Disorder",2,{"name":29,"count":27},"Accidental Falls",{"name":31,"count":27},"Osteoporosis",{"name":33,"count":27},"Frailty",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,69,87,113],{"intervention":44,"totalTrials":9,"cells":45},"alendronate with cholecalciferol",{"EARLY_PHASE1":46,"PHASE1":48,"PHASE2":50,"PHASE3":52,"PHASE4":65,"NA":67},{"trials":47,"activeCount":11},[],{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[54],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":63},"NCT00421343","Secondary Prevention of Osteoporosis","COMPLETED",[39],"2008-06","2007-02",29,[31],[44,64],"calcium carbonate with cholecalciferol",{"trials":66,"activeCount":11},[],{"trials":68,"activeCount":11},[],{"intervention":64,"totalTrials":9,"cells":70},{"EARLY_PHASE1":71,"PHASE1":73,"PHASE2":75,"PHASE3":77,"PHASE4":83,"NA":85},{"trials":72,"activeCount":11},[],{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[79],{"nctId":55,"briefTitle":56,"status":57,"phases":80,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":81,"interventions":82},[39],[31],[44,64],{"trials":84,"activeCount":11},[],{"trials":86,"activeCount":11},[],{"intervention":88,"totalTrials":9,"cells":89},"Scopolamine",{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":96,"PHASE4":98,"NA":100},{"trials":91,"activeCount":11},[],{"trials":93,"activeCount":11},[],{"trials":95,"activeCount":11},[],{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[102],{"nctId":103,"briefTitle":104,"status":57,"phases":105,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":111},"NCT01379001","Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI",[41],"2013-01","2008-07",60,[110],"Cholinergic Function",[88,112],"Donepezil",{"intervention":112,"totalTrials":9,"cells":114},{"EARLY_PHASE1":115,"PHASE1":117,"PHASE2":119,"PHASE3":121,"PHASE4":123,"NA":125},{"trials":116,"activeCount":11},[],{"trials":118,"activeCount":11},[],{"trials":120,"activeCount":11},[],{"trials":122,"activeCount":11},[],{"trials":124,"activeCount":11},[],{"trials":126,"activeCount":11},[127],{"nctId":103,"briefTitle":104,"status":57,"phases":128,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":129,"interventions":130},[41],[110],[88,112]]